{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:18:21Z","timestamp":1761599901999,"version":"build-2065373602"},"reference-count":92,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.autrev.2019.06.010","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T22:27:10Z","timestamp":1559946430000},"page":"761-766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The protease systems and their pathogenic role in juvenile idiopathic arthritis"],"prefix":"10.1016","volume":"18","author":[{"given":"Francesca","family":"Margheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Laurenzana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Giani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Cosmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Annunziato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Cimaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Del Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2019.06.010_bb0005","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.autrev.2017.10.001","article-title":"Novelties in the field of autoimmunity - 1st Saint Petersburg congress of autoimmunity, the bridge between east and west","volume":"16","author":"Dahan","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.06.010_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2018.11.006","article-title":"Juvenile polyautoimmunity in a rheumatology setting","author":"Malag\u00f3n","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.06.010_bb0015","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.autrev.2016.09.012","article-title":"T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies","volume":"15","author":"Maggi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.06.010_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6070067","article-title":"The plasticity of Th17 cells in the pathogenesis of rheumatoid arthritis","volume":"6","author":"Kotake","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2019.06.010_bb0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/1941738109350438","article-title":"The Basic science of articular cartilage. structure, composition, and function","volume":"1","author":"AJS Fox","year":"2009","journal-title":"Sports Health"},{"key":"10.1016\/j.autrev.2019.06.010_bb0030","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.2215\/CJN.04151206","article-title":"Normal bone anatomy and physiology","volume":"3","author":"Clarke","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0035","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.bmc.2007.01.011","article-title":"Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs","volume":"15","author":"Verma","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.autrev.2019.06.010_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbamcr.2009.09.015","article-title":"Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics","volume":"1803","author":"Rodr\u00edguez","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2019.06.010_bb0045","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0092-8674(00)81235-0","article-title":"Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3","volume":"85","author":"Brooks","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2019.06.010_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.autrev.2019.06.010_bb0055","first-page":"119","article-title":"Disruption of matrix metalloproteinase 2 binding to integrin alpha v beta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo","volume":"98","author":"Silletti","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2019.06.010_bb0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1749-6632.1990.tb17943.x","article-title":"Mechanisms of matrix degradation in rheumatoid arthritis","volume":"580","author":"Krane","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2019.06.010_bb0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","article-title":"Physiology and pathophysiology of matrix metalloproteases","volume":"41","author":"Klein","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.autrev.2019.06.010_bb0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0167-4838(99)00279-4","article-title":"Nagase H (2000). \"tissue inhibitors of metalloproteinases: evolution, structure and function\"","volume":"1477","author":"Brew","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2019.06.010_bb0075","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2019.06.010_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.54.1.25","article-title":"Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis","volume":"54","author":"Hembry","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.06.010_bb0085","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nri3499","article-title":"Metalloproteinases and their natural inhibitors in inflammation and immunity","volume":"13","author":"Khokha","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2019.06.010_bb0090","first-page":"826","article-title":"Serum and synovial fluid concentrations of matrix metalloproteinases 3 and its tissue inhibitor 1 in juvenile idiopathic arthritides","volume":"29","author":"Gattorno","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0095","first-page":"1774","article-title":"Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides","volume":"29","author":"Gattorno","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0100","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/kei025","article-title":"Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study","volume":"44","author":"Peake","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2019.06.010_bb0105","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3899\/jrheum.110352","article-title":"Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis","volume":"38","author":"Viswanath","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0110","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/ard.53.11.768","article-title":"Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity","volume":"53","author":"Taylor","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.06.010_bb0115","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/rheumatology\/kei208","article-title":"Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity","volume":"45","author":"Chen","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2019.06.010_bb0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2474-15-93","article-title":"The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases","volume":"15","author":"Sun","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.autrev.2019.06.010_bb0125","first-page":"515","article-title":"Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases","volume":"35","author":"Agarwal","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0130","first-page":"771","article-title":"Induction of metalloproteinases expression by TLR ligands in human fibroblast like synoviocytes from juvenile idiopathic arthritis patients","volume":"131","author":"Agarwal","year":"2010","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.autrev.2019.06.010_bb0135","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.autrev.2017.10.007","article-title":"HLA-DRB1 alleles and juvenile idiopathic arthritis: diagnostic clues emerging from a meta-analysis","volume":"16","author":"De Silvestri","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.06.010_bb0140","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/iub.1446","article-title":"Influence of matrix metalloproteinase 1 and 3 genetic variations on susceptibility and severity of juvenile idiopathic arthritis","volume":"67","author":"Abd-Allah","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.autrev.2019.06.010_bb0145","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/ard.2005.039032","article-title":"Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography","volume":"65","author":"Peake","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.06.010_bb0150","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jor.1100180608","article-title":"Biomechanical regulation of matrix metalloproteinase-9 in cultured chondrocytes","volume":"18","author":"Jin","year":"2000","journal-title":"J Orthop Res"},{"key":"10.1016\/j.autrev.2019.06.010_bb0155","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1172\/JCI115480","article-title":"Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines","volume":"88","author":"Unemori","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2019.06.010_bb0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.15690\/vramn.v68i7.710","article-title":"Indices of matrix metalloproteinases (MMP-2, MMP-9, TIMP-1) with juvenile arthritis in children","volume":"7","author":"Ka\u012dlina","year":"2013","journal-title":"Vestn Ross Akad Med Nauk"},{"key":"10.1016\/j.autrev.2019.06.010_bb0165","first-page":"422","article-title":"Matrix Metalloproteinase-9 production by immortalized human chondrocyte lines","volume":"7","author":"Malemud","year":"2016","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0170","first-page":"125","article-title":"Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition","volume":"8","author":"Grevich","year":"2017","journal-title":"Adolesc Health Med Ther"},{"key":"10.1016\/j.autrev.2019.06.010_bb0175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2119\/molmed.2009.00096","article-title":"Salivary antioxidants and metalloproteinases in juvenile idiopathic arthritis","volume":"16","author":"Brik","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.autrev.2019.06.010_bb0180","first-page":"173","article-title":"Etanercept reduces matrix metalloproteinase-9 level in children with polyarticularjuvenile idiopathic arthritis and TNF-alpha-308GG genotype","volume":"66","author":"Basic","year":"2010","journal-title":"J PhysiolBiochem"},{"key":"10.1016\/j.autrev.2019.06.010_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2011.02.001","article-title":"The pathogenesis of aligoarticular\/polyarticular versus systemic juvenile arthritis","volume":"10","author":"Lin","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.06.010_bb0190","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.4049\/jimmunol.155.12.5483","article-title":"Human IL-17: a novel cytokine derived from T cells","volume":"155","author":"Yao","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0195","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/jcb.22326","article-title":"IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17","volume":"108","author":"Yago","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.autrev.2019.06.010_bb0200","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2019.06.010_bb0205","first-page":"866","article-title":"Dynamic visualization of RANKL and Th17-mediated osteoclast function","volume":"123","author":"Kikuta","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2019.06.010_bb0210","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00296-008-0805-3","article-title":"Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis","volume":"29","author":"Agarwal","year":"2009","journal-title":"Rheumatol Int"},{"issue":"13","key":"10.1016\/j.autrev.2019.06.010_bb0215","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.2741\/3032","article-title":"The plasminogen activation system in inflammation","author":"Del Rosso","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.autrev.2019.06.010_bb0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1015531321445","article-title":"Multiple pathways of cell invasion are regulated by multiple families of serine proteases","volume":"19","author":"Del Rosso","year":"2002","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.autrev.2019.06.010_bb0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/cmi.2016.60","article-title":"uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K\/Akt signaling pathway in patients with rheumatoid arthritis","volume":"15","author":"Liu","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0230","first-page":"364","article-title":"Rheumatoid synovial fibroblasts constitutively express the fibrinolytic pattern of invasive tumor-like cells","volume":"23","author":"Guiducci","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0235","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0024-3205(98)00293-8","article-title":"Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface","volume":"63","author":"Cerinic","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.autrev.2019.06.010_bb0240","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: a versatile signalling orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0245","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.it.2004.06.004","article-title":"uPA and uPAR in fibrinolysis, immunity and pathology","volume":"25","author":"Mondino","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0250","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00018-010-0566-5","article-title":"The plasmin-antiplasmin system: structural and functional aspects","volume":"68","author":"Schaller","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2019.06.010_bb0255","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/jcp.24266","article-title":"\u03b1-2-macroglobulin: a physiological guardian","volume":"228","author":"Rehman","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0260","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jth.13957","article-title":"Measuring fibrinolysis: from research to routine diagnostic assays","volume":"16","author":"Longstaff","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2019.06.010_bb0265","article-title":"The Urokinase plasminogen activation system in rheumatoid arthritis: pathophysiological roles and prospective therapeutic targets","author":"Buckley","year":"2018","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.autrev.2019.06.010_bb0270","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jth.12064","article-title":"Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease","volume":"11","author":"Godier","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2019.06.010_bb0275","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2174\/138161211796718189","article-title":"The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation","volume":"17","author":"Del Rosso","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.autrev.2019.06.010_bb0280","first-page":"1620","article-title":"Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis","volume":"25","author":"Bloom","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0285","first-page":"66","article-title":"Cysteine cathepsins: from structure, function and regulation to new frontiers","volume":"1824","author":"urk","year":"2012","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"10.1016\/j.autrev.2019.06.010_bb0290","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.addr.2004.12.013","article-title":"The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics","volume":"57","author":"Yasuda","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.autrev.2019.06.010_bb0295","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/bj2820273","article-title":"Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues","volume":"282","author":"Buck","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2019.06.010_bb0300","doi-asserted-by":"crossref","first-page":"28669","DOI":"10.1074\/jbc.M204004200","article-title":"Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate","volume":"277","author":"Li","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2019.06.010_bb0305","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/SPC.0b013e32830baea9","article-title":"Cathepsin K inhibitors as treatment of bone metastasis","volume":"2","author":"Le Gall","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.autrev.2019.06.010_bb0310","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/138945007779940188","article-title":"Role of cathepsin K in normal joints and in the development of arthritis","volume":"8","author":"Salminen-Mankonen","year":"2007","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.autrev.2019.06.010_bb0315","first-page":"1607","article-title":"Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice","volume":"149","author":"M\u00fcller-Ladner","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0320","first-page":"103","article-title":"Stimulation of murine macrophage cathepsin B by serum from patients with rheumatoid arthritis: an indicator of disease activity","volume":"51","author":"Ostensen","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0325","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2005.04.001","article-title":"Towards novel anticancer strategies based on cystatin function","volume":"235","author":"Keppler","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.autrev.2019.06.010_bb0330","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S8756-3282(01)00466-5","article-title":"Comparison in localization between cystatin C and cathepsin K in osteoclasts and other cells in mouse tibia epiphysis by immunolight and immunoelectron microscopy","volume":"29","author":"Yamaza","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.autrev.2019.06.010_bb0335","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/art.10114","article-title":"Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium","volume":"46","author":"Hou","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.06.010_bb0340","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fimmu.2011.00052","article-title":"Macrophages in synovial inflammation","volume":"2","author":"Kennedy","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0345","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/bbrc.2001.4787","article-title":"Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis","volume":"283","author":"Hashimoto","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2019.06.010_bb0350","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/art.1780341116","article-title":"Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis","volume":"34","author":"Trabandt","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.06.010_bb0355","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1136\/ard.2010.148635","article-title":"Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups","volume":"70","author":"Finnegan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.06.010_bb0360","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/08916930290031676","article-title":"Expression of cathepsin B, D and L protein in juvenile idiopathic arthritis","volume":"35","author":"Taubert","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2019.06.010_bb0365","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00541377","article-title":"Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes","volume":"7","author":"Velvart","year":"1987","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2019.06.010_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154422","article-title":"LiottaF ,Maggi E, Cosmi L,Del Rosso M, Annunziato F. Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients","volume":"11","author":"Maggi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2019.06.010_bb0375","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/art.1780090106","article-title":"Measurement of synovial fluid pH in normal and arthritic knees","volume":"9","author":"Cummings","year":"1966","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.06.010_bb0380","first-page":"99","article-title":"Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis","volume":"3","author":"Farr","year":"1985","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0385","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/14756366.2016.1217857","article-title":"Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium","volume":"31","author":"Margheri","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.autrev.2019.06.010_bb0390","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2019.06.010_bb0395","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1471-2474-11-279","article-title":"Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis","volume":"11","author":"Chang","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.autrev.2019.06.010_bb0400","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/rheumatology\/keu405","article-title":"Identification of Sj\u00f6gren's syndrome oral fluid biomarker candidates following high-abundance protein depletion","volume":"54","author":"Deutsch","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2019.06.010_bb0405","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1084\/jem.20170355","article-title":"The fate and lifespan of human monocyte subsets in steady state and systemic inflammation","volume":"214","author":"Patel","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2019.06.010_bb0410","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13075-016-1069-z","article-title":"Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?","volume":"18","author":"Gohar","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2019.06.010_bb0415","first-page":"8","article-title":"Biomarkers in juvenile idiopathic arthritis: translating disease mechanisms into diagnostic tools","volume":"9","author":"Foell","year":"2011","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0420","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1021\/pr060129t","article-title":"Proteomic analysis of recurrent joint inflammation in juvenile idiopathic arthritis","volume":"5","author":"Gibson","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.autrev.2019.06.010_bb0425","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1515\/cclm-2014-0441","article-title":"Circulating keratan sulfate as a marker of metabolic changes of cartilage proteoglycan in juvenile idiopathic arthritis; influence of growth factors as well as proteolytic and prooxidative agents on aggrecan alterations","volume":"53","author":"Winsz-Szczotka","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2019.06.010_bb0430","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/ar325","article-title":"Articular cartilage and changes in arthritis: matrix degradation","volume":"3","author":"Mort","year":"2001","journal-title":"Arthritis Res"},{"key":"10.1016\/j.autrev.2019.06.010_bb0435","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.cr.7290106","article-title":"Struct funct aggrecan","volume":"12","author":"Kiani","year":"2002","journal-title":"Cell Res"},{"key":"10.1016\/j.autrev.2019.06.010_bb0440","doi-asserted-by":"crossref","first-page":"7157169","DOI":"10.1155\/2016\/7157169","article-title":"Laboratory indicators of Aggrecan turnover in juvenile idiopathic arthritis","volume":"2016","author":"Winsz-Szczotka","year":"2016","journal-title":"Dis Markers"},{"key":"10.1016\/j.autrev.2019.06.010_bb0445","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.autrev.2017.07.014","article-title":"How I treat juvenile idiopathic arthritis: a state of the art review","volume":"16","author":"Cimaz","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.06.010_bb0450","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clinthera.2017.11.011","article-title":"Phase 1b study of the safety, pharmacokinetics, and disease-related outcomes of the matrix Metalloproteinase-9 inhibitor Andecaliximab in patients with rheumatoid arthritis","volume":"40","author":"Gossage","year":"2018","journal-title":"Clin Ther"},{"key":"10.1016\/j.autrev.2019.06.010_bb0455","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.coph.2018.03.006","article-title":"Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system","volume":"40","author":"Tanaka","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.autrev.2019.06.010_bb0460","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.autrev.2016.07.004","article-title":"Systemic-onset juvenile idiopathic arthritis","volume":"15","author":"Cimaz","year":"2016","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219301375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219301375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:15:35Z","timestamp":1761599735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997219301375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":92,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1568997219301375"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2019.06.010","relation":{},"ISSN":["1568-9972"],"issn-type":[{"type":"print","value":"1568-9972"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The protease systems and their pathogenic role in juvenile idiopathic arthritis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2019.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}